跳至主要内容
临床试验/CTRI/2025/10/096030
CTRI/2025/10/096030尚未招募不适用

A randomized, double-blind, placebo-controlled trial evaluating a probiotic beverage for aging-related biomarkers in Indian adults

CSIR1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年1月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
CSIR
入组人数
120
试验地点
1
主要终点
To find an effective gerobiotic, millet based dietary solution for healthy aging.

研究概览

简要总结

Assess the effect of daily oral supplementation with pearl millet based gerobiotic beverage on biomarkers of oxidative stress, inflammation, brain aging and gut dysbiosis in Indian adults aged 40-65.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Double

入排标准

年龄范围
45.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •include healthy adults aged 40-65 years with BMI 18.5-29.9 kg/m², no chronic diseases, and ability to provide informed consent.

排除标准

  • •encompass diagnosed psychiatric/neurodegenerative disorders, recent antibiotic or probiotic use (within 30 days), pregnancy/lactation, and known allergies to study interventions (ICMR-DBT, 2011; Barzilai et al., 2016).

结局指标

主要结局

To find an effective gerobiotic, millet based dietary solution for healthy aging.

时间窗: week 0 & week 24

次要结局

未报告次要终点

研究者

发起方
CSIR
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Kaila Nova Henna Jemimah

CSIR- CFTRI

研究点 (1)

Loading locations...

相似试验